Literature DB >> 20028085

Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles.

Carlos Tassa1, Jay L Duffner, Timothy A Lewis, Ralph Weissleder, Stuart L Schreiber, Angela N Koehler, Stanley Y Shaw.   

Abstract

Nanoparticles bearing surface-conjugated targeting ligands are increasingly being explored for a variety of biomedical applications. The multivalent conjugation of targeting ligands on the surface of nanoparticles is presumed to enhance binding to the desired target. However, given the complexities inherent in the interactions of nanoparticle surfaces with proteins, and the structural diversity of nanoparticle scaffolds and targeting ligands, our understanding of how conjugation of targeting ligands affects nanoparticle binding remains incomplete. Here, we use surface plasmon resonance (SPR) to directly and quantitatively study the affinity and binding kinetics of nanoparticles that display small molecules conjugated to their surface. We studied the interaction between a single protein target and a structurally related series of targeting ligands whose intrinsic affinity varies over a 4500-fold range and performed SPR at protein densities that reflect endogenous receptor densities. We report that even weak small molecule targeting ligands can significantly enhance target-specific avidity (by up to 4 orders of magnitude) through multivalent interactions and also observe a much broader range of kinetic effects than has been previously reported. Quantitative measurement of how the affinity and kinetics of nanoparticle binding vary as a function of different surface conjugations is a rapid, generalizable approach to nanoparticle characterization that can inform the design of nanoparticles for biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20028085      PMCID: PMC2902264          DOI: 10.1021/bc900438a

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  23 in total

1.  Printing proteins as microarrays for high-throughput function determination.

Authors:  G MacBeath; S L Schreiber
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

2.  A robust small-molecule microarray platform for screening cell lysates.

Authors:  James E Bradner; Olivia M McPherson; Ralph Mazitschek; David Barnes-Seeman; John P Shen; Jasmeet Dhaliwal; Kristen E Stevenson; Jay L Duffner; Seung Bum Park; Donna S Neuberg; Paul Nghiem; Stuart L Schreiber; Angela N Koehler
Journal:  Chem Biol       Date:  2006-05

3.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

Authors:  Seungpyo Hong; Pascale R Leroueil; István J Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Chem Biol       Date:  2007-01

5.  Identifying the proteins to which small-molecule probes and drugs bind in cells.

Authors:  Shao-En Ong; Monica Schenone; Adam A Margolin; Xiaoyu Li; Kathy Do; Mary K Doud; D R Mani; Letian Kuai; Xiang Wang; John L Wood; Nicola J Tolliday; Angela N Koehler; Lisa A Marcaurelle; Todd R Golub; Robert J Gould; Stuart L Schreiber; Steven A Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

6.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.

Authors:  Martin Lundqvist; Johannes Stigler; Giuliano Elia; Iseult Lynch; Tommy Cedervall; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

7.  Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteins.

Authors:  T Keenan; D R Yaeger; N L Courage; C T Rollins; M E Pavone; V M Rivera; W Yang; T Guo; J F Amara; T Clackson; M Gilman; D A Holt
Journal:  Bioorg Med Chem       Date:  1998-08       Impact factor: 3.641

8.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors.

Authors: 
Journal:  Curr Opin Biotechnol       Date:  1997-02-01       Impact factor: 9.740

9.  Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries.

Authors:  Kimberly A Kelly; Stanley Y Shaw; Matthias Nahrendorf; Kelly Kristoff; Elena Aikawa; Stuart L Schreiber; Paul A Clemons; Ralph Weissleder
Journal:  Integr Biol (Camb)       Date:  2009-02-09       Impact factor: 2.192

10.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

View more
  69 in total

1.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

Review 2.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

3.  Binding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand density.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Biotechnol Bioeng       Date:  2011-07-19       Impact factor: 4.530

4.  A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.

Authors:  Hassan Haji-Valizadeh; Christa L Modery-Pawlowski; Anirban Sen Gupta
Journal:  Nanoscale       Date:  2014-05-07       Impact factor: 7.790

5.  A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.

Authors:  Carlos Pérez-Medina; Dalya Abdel-Atti; Yachao Zhang; Valerie A Longo; Chrisopher P Irwin; Tina Binderup; Jesús Ruiz-Cabello; Zahi A Fayad; Jason S Lewis; Willem J M Mulder; Thomas Reiner
Journal:  J Nucl Med       Date:  2014-07-24       Impact factor: 10.057

Review 6.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

7.  Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.

Authors:  Mikyung Yu; Jaume Amengual; Arjun Menon; Nazila Kamaly; Felix Zhou; Xiaoding Xu; Phei Er Saw; Seung-Joo Lee; Kevin Si; Carleena Angelica Ortega; Won Il Choi; In-Hyun Lee; Yazan Bdour; Jinjun Shi; Morteza Mahmoudi; Sangyong Jon; Edward A Fisher; Omid C Farokhzad
Journal:  Adv Healthc Mater       Date:  2017-07-21       Impact factor: 9.933

8.  Mechanistic insights into the pH-dependent membrane peptide ATRAM.

Authors:  Vanessa P Nguyen; Loganathan Palanikumar; Stephen J Kennel; Daiane S Alves; Yujie Ye; Jonathan S Wall; Mazin Magzoub; Francisco N Barrera
Journal:  J Control Release       Date:  2019-02-11       Impact factor: 9.776

9.  Binding Site Geometry and Subdomain Valency Control Effects of Neutralizing Lectins on HIV-1 Viral Particles.

Authors:  Sabrina Lusvarghi; Katheryn Lohith; Jeanne Morin-Leisk; Rodolfo Ghirlando; Jenny E Hinshaw; Carole A Bewley
Journal:  ACS Infect Dis       Date:  2016-10-03       Impact factor: 5.084

10.  Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies.

Authors:  U Iqbal; H Albaghdadi; Y Luo; M Arbabi; C Desvaux; T Veres; D Stanimirovic; A Abulrob
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.